escalitopram
Trade name: Lexapro
Small moleculeexperimental
Clinical trial activity
9 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
5
Phase 4
1
Earliest trial started Jul 1, 2001 (NCT00749125)
Timeline
Indications
Approved for
Mechanism of action
- Serotonin 4 (5-HT4) receptorINHIBITOR
HTR4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- escalitopram
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01123707 | Phase 3 | Nov 1, 2010 | Otsuka |
| NCT01111565 | Phase 3 | Jul 1, 2010 | Otsuka |
| NCT01111539 | Phase 3 | Jul 1, 2010 | Otsuka |
| NCT01111552 | Phase 3 | Jul 1, 2010 | Otsuka |
| NCT01090700 | Phase 1 | May 1, 2010 | Tibotec |
| NCT00933894 | Phase 1 | Sep 1, 2009 | Tibotec |
| NCT01541475 | Phase 4 | Mar 1, 2009 | Ewha Womans University, GlaxoSmithKline |
| NCT00215228 | Phase 2/Phase 3 (Phase 3) | Jul 1, 2005 | Duke University, Forest Laboratories |
| NCT00749125 | N/A | Jul 1, 2001 | National Institute of Mental Health (NIMH), Washington University in St. Louis |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Otsuka | For profit | 4 | 4 | 1 | 2010 |
| Tibotec | For profit | 2 | 2 | 1 | 2009 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Ewha Womans University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Forest Laboratories | For profit | 1 | 0 | 1 | 2005 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2009 |
| National Institute of Mental Health (NIMH) | Government | 1 | 1 | 1 | 2001 |
| Washington University in St. Louis | Academic/Hospital | 1 | 0 | 1 | 2001 |
8 organizations
Page 1 / 1